These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28582488)

  • 1. Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis.
    Kwak N; Park J; Kim E; Lee CH; Han SK; Yim JJ
    Clin Infect Dis; 2017 Oct; 65(7):1077-1084. PubMed ID: 28582488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review.
    Diel R; Nienhaus A; Ringshausen FC; Richter E; Welte T; Rabe KF; Loddenkemper R
    Chest; 2018 Apr; 153(4):888-921. PubMed ID: 29410162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis.
    Nasiri MJ; Ebrahimi G; Arefzadeh S; Zamani S; Nikpor Z; Mirsaeidi M
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):263-273. PubMed ID: 31986933
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
    Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis.
    Park Y; Lee EH; Jung I; Park G; Kang YA
    Respir Res; 2019 Dec; 20(1):286. PubMed ID: 31852452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of nontuberculous mycobacterial disease.
    Griffith DE
    Curr Opin Infect Dis; 2007 Apr; 20(2):198-203. PubMed ID: 17496580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
    Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
    Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
    Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin liposome and Mycobacterium avium complex: A systematic review.
    Zangiabadian M; Malekshahian D; Arabpour E; Abadi SSD; Yazarlou F; Bostanghadiri N; Centis R; Aghababa AA; Farahbakhsh M; Nasiri MJ; Sotgiu G; Migliori GB
    PLoS One; 2022; 17(12):e0279714. PubMed ID: 36574432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for Mycobacterium avium complex lung disease.
    Pan SW; Shu CC; Feng JY; Su WJ
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S67-S75. PubMed ID: 32446754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Duration of Aminoglycoside Treatment and Outcome of Cavitary Mycobacterium avium Complex Lung Disease.
    Kim OH; Kwon BS; Han M; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
    Clin Infect Dis; 2019 May; 68(11):1870-1876. PubMed ID: 30239615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE
    Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.